Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-20-238219
Filing Date
2020-09-02
Accepted
2020-09-02 17:18:59
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d947995dsc13da.htm SC 13D/A 48278
  Complete submission text file 0001193125-20-238219.txt   49653
Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017
Business Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Subject) CIK: 0000810509 (see all company filings)

EIN.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-43603 | Film No.: 201157607
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 5251 DTC PARKWAY, SUITE 285 GREENWOOD VILLAGE CO 80111
Business Address
Scott John K Jr. (Filed by) CIK: 0001753763 (see all company filings)

Type: SC 13D/A